ACE2 |
Angiotensin-converting enzyme 2 |
AIDS |
Acquired immunodeficiency syndrome |
ARDS |
Acute respiratory distress syndrome |
CBC |
Cannabichromene |
CBCA |
Cannabichromenic acid |
CBD |
Cannabidiol |
CBDA |
Cannabidiolic acid |
CBDV |
Cannabidivarin |
CBDVM |
Cannabidivarin methyl ester |
CBE |
Cannabielsoin |
CBG |
Cannabigerol |
CBL |
Cannabicyclol |
CBN |
Cannabinol |
CBT |
Cannabitriol |
CBV |
Cannabivarin |
CDC |
Centers for disease control and prevention |
CNS |
Central nervous system |
DNA |
Deoxyribonucleic acid |
EC |
Endocannabinoid |
EO |
Essential oil |
FDA |
Food and drug administration |
GNB |
Gram-negative bacteria |
GPB |
Gram-positive bacteria |
HMVEC |
Human microvascular endothelial cells |
HOMO |
Highest occupied molecular orbital |
IL |
Interleukin |
KSHV |
Kaposi sarcoma associated herpesvirus |
LPS |
Lipopolysaccharide |
LUMO |
Lowest unoccupied molecular orbital |
MBEC |
Minimum biofilm eradication concentration |
MD |
Molecular dynamic |
MIC |
Minimum inhibitory concentration |
MRSA |
Methicillin-resistant Staphylococcus aureus
|
MSSA |
Methicillin-susceptible Staphylococcus aureus
|
MV |
Membrane vesicle |
PBP |
Penicillin-binding proteins |
QIDP |
Qualified infectious disease product |
QSAR |
Quantitative structure-activity relationship |
RNA |
Ribonucleic acid |
R&D |
Research and Development |
SARS-CoV |
Severe acute respiratory syndrome coronavirus |
THC |
Tetrahydrocannabinol |
THCA |
Tetrahydrocannabinolic acid |
TMPRSS2 |
Transmembrane protease, serine 2 |
TNF-α |
Tumor necrosis factor |
VISA |
Vancomycin-intermediate Staphylococcus aureus
|
VRSA |
Vancomycin-resistant Staphylococcus aureus
|
WHO |
World health organization |